Daxor EBITDA Margin 2010-2011 | DXR

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Daxor (DXR) over the last 10 years. The current EBITDA margin for Daxor as of December 31, 2011 is .
Daxor EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2011-12-31 $0.00B $-0.01B 0.00%
2011-09-30 $0.00B $-0.01B 0.00%
2011-06-30 $0.00B $-0.01B 0.00%
2011-03-31 $0.00B $-0.01B 0.00%
2010-12-31 $0.00B $0.00B 0.00%
2010-09-30 $0.00B $0.00B 0.00%
2010-06-30 $0.00B $0.00B 0.00%
2010-03-31 $0.00B $0.00B 0.00%
2009-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.048B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.421B 19.14
Encompass Health (EHC) United States $12.034B 25.51
DaVita (DVA) United States $10.782B 15.16
Elanco Animal Health (ELAN) United States $7.186B 15.39
Chemed (CHE) United States $6.740B 21.18
Option Care Health (OPCH) United States $5.061B 22.56
RadNet (RDNT) United States $4.146B 263.14
Amedisys (AMED) United States $3.167B 21.30
Addus HomeCare (ADUS) United States $2.035B 22.35
LifeStance Health (LFST) United States $1.818B 0.00
Astrana Health (ASTH) United States $1.354B 33.54
U.S Physical Therapy (USPH) United States $1.206B 31.12
Pennant (PNTG) United States $0.891B 32.72
Aveanna Healthcare Holdings (AVAH) United States $0.839B 47.78
Atai Life Sciences (ATAI) Germany $0.551B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.040B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00